Table 2.
P9201 (n=24) | P9605 (n=35) | P value | |
---|---|---|---|
Gender (n/%) | 0.43 | ||
male | 15 (62.5%) | 17 (48.6%) | |
female | 9 (37.5%) | 28 (51.4%) | |
Race (n/%) | 0.16 | ||
White, non-hispanic | 16 (66.7%) | 31 (88.6%) | |
Black, non-hispanic | 1 (4.2%) | 2 (5.7%) | |
Filipino | 1 (4.2%) | 0 (0%) | |
Native American | 1 (4.2%) | 0 (0%) | |
Hispanic | 5 (20.8%) | 2 (5.7%) | |
Age at diagnosis* | 4.1 (1.1-7.5) | 4.9 (2.3-9.8) | 0.09 |
Diagnosis to NP test*^ | 8.0 (6.1-9.6) | 7.7 (5.2-10.9) | 0.48 |
Diagnosis to MRI*^ | 7.7 (5.1-9.6) | 7.8 (5.2-10.2) | 0.74 |
End of treatment to NP test*^ | 5.6 (3.5-7.1) | 5.2 (2.6-8.3) | 0.25 |
End of treatment to MRI*^ | 5.3 (2.6-7.1) | 5.3 (2.7-7.7) | 0.94 |
mean/range in years
Only include patients with the particular test, as not all patients had both.